Fri, Jun 27, 4:12 PM (16 days ago)
**Summary of Xenous Holdings, Inc. (XITO) 10-K Fiscal Year Ended March 31, 2025** **Financial Performance:** - **Revenue:** $0 (no operations) - **Net Income:** $(64,456) (net loss) - **Operating Expenses:** $64,456 - **Earnings per Share:** $(0.00) **Strategic Overview:** - Xenous Holdings, Inc. is a shell company seeking potential assets, property, or businesses to acquire. - No material business operations; plan to consider industries, adopt business plans, and commence operations through acquisition. - Evaluating potential acquisition of Dadvance Agarwood Alpha Sdn Bhd (Dadvance), but no definitive transaction finalized. **Future Outlook:** - Continued evaluation of Dadvance's commercial viability and strategic fit. - Potential acquisition contingent on conversion of strategic leads, confirmation of supply chain scalability, market feasibility studies, and fairness opinion. **Risk Factors:** - Limited resources and competitive disadvantage compared to entities with significant cash resources. - Dependence on advances from principal shareholders for continued funding. - Substantial doubt about the company's ability to continue as a going concern. **Financial Condition:** - **Current Assets:** $0 - **Current Liabilities:** $903,622 - **Working Capital Deficit:** $(903,622) - **Stockholders' Deficit:** $(903,622) - **Cash Flow from Operating Activities:** $(63,637) - **Cash Flow from Financing Activities:** $63,637 **Market Position Changes:** - Common stock quoted on OTC Pink Sheets under the symbol "XITO." - 760,250,000 shares of common stock issued and outstanding as of June 20, 2025. - No established trading market for shares; resale exemptions under Rule 144 currently unavailable for 707,050,000 shares. **Amendment Note:** - No specific amendments mentioned in the provided text. Focus on changes, reasons, and impact would require additional context.